Masato Tanabe

Title: The Innovative Contributions of Masato Tanabe in Therapeutic Steroid Synthesis

Introduction

Masato Tanabe, based in Palo Alto, California, is a prolific inventor with a remarkable portfolio of 27 patents. His work primarily revolves around the synthesis of therapeutic steroids, showcasing significant potential in the medical field, particularly in the treatment of prostate disorders.

Latest Patents

Among his notable contributions are his latest patents focused on the synthesis of anti-estrogenic and other therapeutic steroids derived from 21-hydroxy-19-norpregna-4-en-3-one. Specifically, he has developed processes for synthesizing steroids such as 3-hydroxy-7α-methyl-21-[2'-methoxy-4′-(diethylaminomethyl)-phenoxy]-19-norpregna-1,3,5(10)triene citrate, also known as "SR 16234". These advancements highlight the utility of 21-hydroxy-19-norpregna-4-en-3-one in providing valuable intermediates that could serve as therapeutic agents in managing conditions like prostatic cancer.

Career Highlights

Tanabe has held significant positions at renowned organizations, including SRI International and Japan Tobacco Inc. His tenure at these companies has allowed him to leverage his expertise in steroid synthesis, advancing both his career and the field of pharmaceuticals.

Collaborations

Throughout his professional journey, Tanabe has collaborated with other talented scientists, such as Richard H. Peters and Wan-Ru Chao. These partnerships have contributed to the successful development of innovative compounds and methodologies within the field.

Conclusion

Masato Tanabe's impressive array of patents and his collaborative efforts underscore his vital role in the innovation of therapeutic steroid synthesis. His work not only enhances scientific understanding but also holds promise for improving treatment options in oncology and other medical areas.